Literature DB >> 22670001

Diagnostic uncertainty around seizures in advanced malignancy.

Demiana Lenzi Lewis-Hanna1, Gurjeet Pamma.   

Abstract

A 70-year-old lady with a resected Dukes B colon cancer, receiving adjuvant capecitabine and bevacizumab chemotherapy was admitted with Hickman line sepsis. During her admission, she developed seizures and periods of unresponsiveness and was suspected to have brain metastases. She was started on high dose steroids and sodium valproate and appeared to respond to this treatment. However an MRI scan revealed that she did not have brain metastases but a rare neurological condition called reversible posterior leukoencephalopathy syndrome, which can be fatal if not treated but has a good prognosis if the cause is identified and treated.

Entities:  

Mesh:

Year:  2011        PMID: 22670001      PMCID: PMC3246152          DOI: 10.1136/bcr.05.2011.4265

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Reversible posterior leukoencephalopathy syndrome and bevacizumab.

Authors:  Peter Glusker; Larry Recht; Barton Lane
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Reversible posterior leukoencephalopathy syndrome and bevacizumab.

Authors:  Cevher Ozcan; Stuart J Wong; Parameswaran Hari
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.

Authors:  M T Russell; A S Nassif; E D Cacayorin; E Awwad; W Perman; F Dunphy
Journal:  Magn Reson Imaging       Date:  2001-01       Impact factor: 2.546

Review 4.  Posterior leukoencephalopathy syndrome.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

5.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

6.  A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome.

Authors:  Eun Jin Kwon; Se Won Kim; Kwang Ki Kim; Hyung Suk Seo; Do Yeun Kim
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

7.  Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.

Authors:  Anita Rajasekhar; Thomas J George
Journal:  Oncologist       Date:  2007-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.